Shanghai Roche Pharmaceuticals Limited

Shanghai Roche Pharmaceuticals Limited, founded in 1994, is the market leader in key areas of oncology, virology, and transplant.
Roche China is committed to helping patients achieve meaningful improvements in quality of life and in survival by putting patients at the core of everything it does. Through its current portfolio of 16 products, Roche covers eight treatment areas in China. Roche works closely with a broad range of stakeholders including the government, healthcare institutions, and NGOs to explore innovative models of cooperation, aiming to bring tangible and sustainable benefit to more patients in China.